Myrobalan Therapeutics

About:

Myrobalan Therapeutics is a biotech firm that develops oral neurorestorative therapies to reverse key brain dysfunctions and CNS conditions.

Website: https://myrotx.com

Top Investors: The ALS Association, Cowin Venture, 3E Bioventures, Guanzi Capital, AB Magnitude Ventures Group

Description:

Myro Therapeutics is a biotechnology company that focuses on the development of therapeutic solutions for Central Nervous System (CNS) disorders. The company's approach is rooted in a deep understanding of disease biology and mechanisms, which allows for the selection of targets that can effectively combat these disorders. Myro Therapeutics has a dedicated team of scientists who work tirelessly to advance the company's research and development efforts.

Total Funding Amount:

$33.4M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Medford, Massachusetts, United States

Founded Date:

2021-01-01

Contact Email:

info(AT)myrotx.com

Founders:

Guoping Feng, Jing Wang, Zhigang He

Number of Employees:

11-50

Last Funding Date:

2024-07-29

IPO Status:

Private

Industries:

© 2025 bioDAO.ai